ksqtx.comBioTechFounded: 2015Funding to Date: $157.46MM
KSQ Therapeutics is the developer of a genome-scale precision functional genomics platform, called CRISPRomics, designed to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed.
For more details on financing and valuation for KSQ Therapeutics, register or login.
Already registered? Click here to log in
To read this article and more news on KSQ Therapeutics, register or login.
Already registered? Click here to log in.
Forge and SharesPost have teamed up to provide you with an enhanced trading experience.